Tech Company Financing Transactions
CaloSyn Pharma Funding Round
On 6/30/2009, CaloSyn Pharma received $400 thousand in funding from BVM Capital and MB Venture Partners.
Transaction Overview
Company Name
Announced On
6/30/2009
Transaction Type
Venture Equity
Amount
$400,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
26 Firebrick Rd.
Sharon, MA 02067
USA
Sharon, MA 02067
USA
Phone
Email Address
Not Recorded
Overview
The company is developing intra-articular therapeutics for osteoarthritis.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Martin Becker
Chief Executive Officer
Stephen Snowdy
Browse more venture capital transactions:
Prev: 6/30/2009: Body Evolution venture capital transaction
Next: 6/30/2009: AirPlay Network venture capital transaction
Share this article
Where The Data Comes From
We do our best to record tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs